Understand the source comparison
How Does Adamax Work: Melanotropic Peptide Comparison
Before selecting Adamax for melanogenesis research, understanding how it compares mechanistically and practically to MT-2 and endogenous α-MSH clarifies which tool fits which experimental question. | Peptide | MC1R Selectivity | Half-Life | Typical Dose Range
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before selecting Adamax for melanogenesis research, understanding how it compares mechanistically and practically to MT-2 and endogenous α-MSH clarifies which tool fits which experimental question.
- | Peptide | MC1R Selectivity | Half-Life | Typical Dose Range | Primary Off-Target Effects | Onset to Visible Pigmentation | Bottom Line ||—|—|—|—|—|—|| Endogenous α-MSH | Low (binds MC1R–MC5R broadly) | ~20 minutes | N/A (endogenous) | Anti-inflammatory signaling (MC1R/MC3R), appetite modulation (MC4R) | Requires continuous UV exposure | Natural ligand. Short half-life makes it impractical for exogenous use; primarily a reference standard || Melanotan II (MT-2) | Moderate (strong MC1R + significant MC3R/MC4R activity) | ~60 minutes | 0.25–1mg/day loading; 0.25–0.5mg 2–3×/week maintenance | Appetite suppression, spontaneous erections, nausea, flushing | 3–5 days | Fastest visible pigmentation but highest incidence of non-melanogenic side effects; best for MC4R co-study || Adamax | High (preferential MC1R, reduced MC3R/MC4R) | ~90–120 minutes | 0.5–1mg/day loading; 0.25–0.5mg 1–3×/week maintenance | Minimal appetite effects; transient nausea in ~15–20% during loading | 5–7 days | Cleane
- Adamax work is optimized for studies where MC1R pathway activation is the primary endpoint and off-target melanocortin receptor activity would confound results. MT-2 remains the reference compound in studies examining multi-receptor melanocortin signaling or appetite-pigmentation interaction, but for pure melanogenesis research, Adamax offers superior selectivity.